About Oncology Trials Insights
Oncology Trials Insights is a Pharmaceuticals company, headquartered in Denver, with 11 - 50 employees and annual revenue of $5M - $20M.
Oncology Trials Insights (OTI) is a clinical trials strategy company and is focused specifically in the oncology space. OTI was cofounded by an oncology KOL and has recruited more than 90 of the world's top oncology minds to work with the company. Unlike the full-service solutions offered by a CRO, ...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Oncology Trials Insights Company Highlights
Phone Number
(303) 759-xxxx
Corporate Office Address
501 S Cherry Street
Denver, 80246
Website
Oncology Trials Insights Org
Oncology Trials Insights's Tech Stack
Frequently Asked Questions About
Oncology Trials Insights
Log in or sign up to get full contact details and additional support.
What technologies does Oncology Trials Insights use?
Oncology Trials Insights uses technologies including Font Awesome, Fusion Ads, and Gravatar.
How do I contact Oncology Trials Insights?
To contact Oncology Trials Insights, visit onctrials.com.
What companies are similar to Oncology Trials Insights?
Companies similar to Oncology Trials Insights include MSD Animal Health, Madrigal Pharmaceuticals, and Pharmaceutical Industry.
Where is Oncology Trials Insights headquartered?
Oncology Trials Insights is headquartered at 501 S Cherry Street, Denver.
What is the main phone number for Oncology Trials Insights?
The main phone number for Oncology Trials Insights is (303) 759-xxxx.
What is the official website for Oncology Trials Insights?
The official website for Oncology Trials Insights is onctrials.com.
What is the annual revenue of Oncology Trials Insights?
The annual revenue of Oncology Trials Insights is $5M - $20M.
How many employees does Oncology Trials Insights have?
Oncology Trials Insights has 11 - 50 employees.
What industry is Oncology Trials Insights in?
Oncology Trials Insights is in the Pharmaceuticals industry.
Last updated: August 19, 2024